New Scientist reports that a group of addiction researchers have filed a patent on a method for producing antibodies that can clean the bloodstream of “designer drugs” from the amphetamine family.
It’s not yet been tested in humans, of course, but the implication is that injections of these antibodies could eradicate the chemicals in question from a patients body, which would doubtless be of great assistance in withdrawal programs. [image from erowid.org]
But as we all know, the street finds its own use for things. Once stuff like this hits the black market, I think there’ll be a lot less people worrying about mandatory drug testing in the workplace.